88 related articles for article (PubMed ID: 17162379)
1. HIV-1 Tat triggers TGF-beta production and NK cell apoptosis that is prevented by pertussis toxin B.
Poggi A; Zocchi MR
Clin Dev Immunol; 2006; 13(2-4):369-72. PubMed ID: 17162379
[TBL] [Abstract][Full Text] [Related]
2. Pertussis toxin (PTX) B subunit and the nontoxic PTX mutant PT9K/129G inhibit Tat-induced TGF-beta production by NK cells and TGF-beta-mediated NK cell apoptosis.
Zocchi MR; Contini P; Alfano M; Poggi A
J Immunol; 2005 May; 174(10):6054-61. PubMed ID: 15879099
[TBL] [Abstract][Full Text] [Related]
3. Pertussis toxin B-oligomer suppresses human immunodeficiency virus-1 Tat-induced neuronal apoptosis through feedback inhibition of phospholipase C-beta by protein kinase C.
Jajoo S; Mukherjea D; Brewer GJ; Ramkumar V
Neuroscience; 2008 Jan; 151(2):525-32. PubMed ID: 18093742
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Tat inhibits human natural killer cell function by blocking L-type calcium channels.
Zocchi MR; Rubartelli A; Morgavi P; Poggi A
J Immunol; 1998 Sep; 161(6):2938-43. PubMed ID: 9743356
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer.
Rizzi C; Alfano M; Bugatti A; Camozzi M; Poli G; Rusnati M
Eur J Immunol; 2004 Feb; 34(2):530-6. PubMed ID: 14768058
[TBL] [Abstract][Full Text] [Related]
6. Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS.
Cupp C; Taylor JP; Khalili K; Amini S
Oncogene; 1993 Aug; 8(8):2231-6. PubMed ID: 8336945
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells.
Caldwell RL; Gadipatti R; Lane KB; Shepherd VL
J Leukoc Biol; 2006 Jan; 79(1):192-201. PubMed ID: 16282533
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat protein and its inhibitor Ro 24-7429 inhibit lymphocyte proliferation and induce apoptosis in peripheral blood mononuclear cells from healthy donors.
Patki AH; Lederman MM
Cell Immunol; 1996 Apr; 169(1):40-6. PubMed ID: 8612292
[TBL] [Abstract][Full Text] [Related]
9. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.
Faller E; Kakal J; Kumar R; Macpherson P
Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839
[TBL] [Abstract][Full Text] [Related]
10. The expression of CD154 by Kaposi's sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-TAT protein.
Cantaluppi V; Deregibus MC; Biancone L; Deambrosis I; Bussolati B; Albini A; Camussi G
Int J Immunopathol Pharmacol; 2006; 19(1):81-96. PubMed ID: 16569346
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
Kopp HG; Placke T; Salih HR
Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
[TBL] [Abstract][Full Text] [Related]
12. RCAS1 induced by HIV-Tat is involved in the apoptosis of HIV-1 infected and uninfected CD4+ T cells.
Minami R; Yamamoto M; Takahama S; Miyamura T; Watanabe H; Suematsu E
Cell Immunol; 2006 Sep; 243(1):41-7. PubMed ID: 17250817
[TBL] [Abstract][Full Text] [Related]
13. Beta(3)-mediated engulfment of apoptotic tumor cells by dendritic cells is dependent on CAMKII: inhibition by HIV-1 Tat.
Poggi A; Carosio R; Rubartelli A; Zocchi MR
J Leukoc Biol; 2002 Mar; 71(3):531-7. PubMed ID: 11867691
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression.
Yoon SJ; Heo DS; Kang SH; Lee KH; Kim WS; Kim GP; Lee JA; Lee KS; Bang YJ; Kim NK
Anticancer Res; 1998; 18(3A):1591-6. PubMed ID: 9673375
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection.
Fanales-Belasio E; Moretti S; Fiorelli V; Tripiciano A; Pavone Cossut MR; Scoglio A; Collacchi B; Nappi F; Macchia I; Bellino S; Francavilla V; Caputo A; Barillari G; Magnani M; Laguardia ME; Cafaro A; Titti F; Monini P; Ensoli F; Ensoli B
J Immunol; 2009 Mar; 182(5):2888-97. PubMed ID: 19234184
[TBL] [Abstract][Full Text] [Related]
16. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
17. Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis.
Barreto-de-Souza V; Pacheco GJ; Silva AR; Castro-Faria-Neto HC; Bozza PT; Saraiva EM; Bou-Habib DC
J Infect Dis; 2006 Sep; 194(6):846-54. PubMed ID: 16941353
[TBL] [Abstract][Full Text] [Related]
18. Pertussis toxin and its binding unit inhibit HIV-1 infection of human cervical tissue and macrophages involving a CD14 pathway.
Hu Q; Younson J; Griffin GE; Kelly C; Shattock RJ
J Infect Dis; 2006 Dec; 194(11):1547-56. PubMed ID: 17083039
[TBL] [Abstract][Full Text] [Related]
19. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S
Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245
[TBL] [Abstract][Full Text] [Related]
20. The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells.
Romano S; Mallardo M; Chiurazzi F; Bisogni R; D'Angelillo A; Liuzzi R; Compare G; Romano MF
Haematologica; 2008 Jul; 93(7):1039-48. PubMed ID: 18492692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
